Opportunities and Challenges of Population Pharmacogenomics
ABSTRACT Pharmacological responses can vary significantly among patients from different ethnogeographic backgrounds. This variability can, at least in part, be attributed to population‐specific genetic patterns in genes involved in drug absorption, distribution, metabolism, and excretion, as well as in genes associated with drug‐induced toxicity ...
Yitian Zhou+3 more
wiley +1 more source
Use of Crithidia fasciculata extract for the facile enzymatic synthesis of GDP-L-[3H]Fucose. [PDF]
Paredes Franco JC+2 more
europepmc +1 more source
Cryptorchidism: Novel genetic insights into CCDC149 mutations
Abstract Background Cryptorchidism, characterized by the failure of one or both testes to descend into the scrotum, is a common congenital condition that can lead to infertility and increased risk of testicular cancer. CCDC149, a coiled‐coil domain‐containing protein, has been implicated in various developmental processes, but its role in the male ...
Shengrong Du+8 more
wiley +1 more source
Whole Blood Metabolomic Profiling of Mice with Tacrolimus-Induced Chronic Nephrotoxicity: NAD+ Depletion with Salvage Pathway Impairment. [PDF]
Nishida S+4 more
europepmc +1 more source
This study demonstrates the clinical utility of a next‐generation sequencing (NGS)‐based chimerism assay (CASAL) in haematopoietic stem cell transplantation (HSCT). Compared to conventional short tandem repeat (STR) methods, CASAL showed significantly higher marker informativeness, detecting mixed chimerism (MC) below 5% recipient DNA with a median of ...
Jin Ju Kim+7 more
wiley +1 more source
De novo NAD<sup>+</sup> synthesis is ineffective for NAD<sup>+</sup> supply in axenically cultured Caenorhabditis elegans. [PDF]
Zhu S+6 more
europepmc +1 more source
Gastrointestinal jumbo phages possess independent synthesis and utilization systems of NAD. [PDF]
Li C+11 more
europepmc +1 more source
Advances in Engineering Nucleotide Sugar Metabolism for Natural Product Glycosylation in Saccharomyces cerevisiae. [PDF]
Crowe SA+4 more
europepmc +1 more source
α-Ketoglutarate dehydrogenase is a therapeutic vulnerability in acute myeloid leukemia.
Millman SE+18 more
europepmc +1 more source